The gastrointestinal stromal tumor (GIST) market is witnessing rapid transformation driven by innovative therapies and expanding patient awareness. This industry is characterized by dynamic market trends and sustained growth due to advancements in molecular diagnostics and targeted treatment options tailored for GIST patients. An analysis of the market size and forecast further reflects the...
Greek
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)